Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Relation between debrisoquine oxidation phenotype and morphological, biological, and pathological variables in a large population.

Clinical chemistry - 1 Mar 1991

Vincent-Viry M, Muller J, Fournier B, Galteau M M, Siest G

Abstract excerpt

Factors affecting biological variations in debrisoquine-oxidation polymorphism were investigated in a population of 3065 unrelated supposedly healthy Caucasian subjects, ages 35 to 50 years. This population, including 1526 men and 1539 women, was used to determine whether the debrisoquine-oxidation phenotype can be related with environmental factors such as alcohol intake, smoking habits or medication; with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Oral
Share to Alcohol Drinking

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Debrisoquin

Share to Hydroxylation

Share to Phenotype

Share to Polymorphism, Genetic

Share to Sex Factors

Share to Smoking

Source

Identifiers

PMID: 2004438

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Relation between debrisoquine oxidation phenotype and morphological, biological, and pathological variables in a large population.PMID 2004438Read ↗

Polymorphic debrisoquin metabolism in a Turkish population.Semantic proximity Read ↗

Determination of debrisoquine oxidation phenotype in healthy volunteers during phase I trials.Semantic proximity Read ↗

Debrisoquine metabolism and lung cancer risk.Semantic proximity Read ↗

Disposition of debrisoquine in Caucasians with different CYP2D6-genotypes including those with multiple genes.Semantic proximity Read ↗

Pharmacogenetics of Debrisoquine and its Use as a Marker For CYP2D6 Hydroxylation CapacitySemantic proximity Read ↗

Debrisoquine oxidation in an Italian population: a study in healthy subjects and in schizophrenic patients.Semantic proximity Read ↗

Lack of relationship between debrisoquine oxidation phenotype and the pharmacokinetics of quinine.Semantic proximity Read ↗

Genetic and metabolic criteria for the assignment of debrisoquine 4-hydroxylation (cytochrome P4502D6) phenotypes.Semantic proximity Read ↗

Debrisoquine hydroxylation phenotyping in geriatric psychopharmacology.Semantic proximity Read ↗

3,4-Dehydrodebrisoquine, a novel debrisoquine metabolite formed from 4-hydroxydebrisoquine that affects the CYP2D6 metabolic ratio.Semantic proximity Read ↗

Metabolism of almitrine in extensive and poor metabolisers of debrisoquine/sparteine.Semantic proximity Read ↗

The relationship between debrisoquine oxidation phenotype and the pharmacokinetics of chlorpropamide.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.